PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27867811-0	2016	Dramatic mitigation of bone pain after phosphorus replacement therapy in a subject with FGF23-related hypophosphatemic osteomalacia.	Phosphorus	39-49	fibroblast growth factor 23	Homo sapiens	88-93	
27867811-1	2016	INTRODUCTION: Fibroblast growth factor 23 (FGF23) is secreted from bone and suppresses the absorption of phosphorus in renal proximal tubule and in intestinal tract.	Phosphorus	105-115	fibroblast growth factor 23	Homo sapiens	14-41	
27867811-1	2016	INTRODUCTION: Fibroblast growth factor 23 (FGF23) is secreted from bone and suppresses the absorption of phosphorus in renal proximal tubule and in intestinal tract.	Phosphorus	105-115	fibroblast growth factor 23	Homo sapiens	43-48	
27867811-7	2016	CONCLUSIONS: We should be aware of the possibility that phosphorus replacement therapy exert marked beneficial effects for the reduction of bone pain in subjects with FGF23-related hypophosphatemic osteomalacia even when we fail to identify tumor localization.	Phosphorus	56-66	fibroblast growth factor 23	Homo sapiens	167-172